Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Lipocalin 2 (LCN2)
100%
Region of Birth
77%
Native-born
77%
Inter-variability
77%
Inter-individual Variability
77%
Inflammation Markers
77%
Monogenic
77%
Low Dose Rate
77%
CARD11
77%
Externalizing Behavior
77%
Very Early Onset
77%
Colitis
77%
Protein Loss
77%
Cystic Fibrosis
77%
Intraindividual Variability
77%
Heterozygous Variant
77%
Celiac Disease
77%
Pediatric Celiac Disease
77%
Enteric Infections
77%
Non-invasive Markers
77%
Immigrant Youth
77%
VEO-IBD
51%
Alpha-1 Antitrypsin
44%
Celiac Serology
44%
Fecal Calprotectin
44%
Stool
44%
Forced Expiratory Volume in 1 Second (FEV1)
33%
LRBA Deficiency
25%
Gastrointestinal Diseases
25%
Abatacept
25%
Very Young
25%
Chronic Colitis
25%
Pediatric Patients
25%
Bloody Diarrhea
25%
Gastroenterology
25%
Very Early-onset Inflammatory Bowel Disease
25%
Gene Variants
25%
Inflammatory Bowel Disease
25%
Primary Immunodeficiency
25%
De-novo mutations
25%
Abdominal Pain
25%
Weight Loss
25%
Granuloma
25%
Clinical Remission
25%
Whole Exome Sequencing
25%
Single Gene Disorders
25%
Compound Heterozygous mutation
25%
Histopathologic
25%
Serologic Findings
22%
Body Mass Index
22%
Medicine and Dentistry
Neutrophil Gelatinase Associated Lipocalin
94%
Inflammation
88%
Coeliac Disease
77%
Pediatrics
77%
Cystic Fibrosis
77%
Protein Depletion
77%
Faecal Calprotectin
43%
Alpha 1 Antitrypsin
38%
Biopsy Technique
29%
Gut
22%
Lipopolysaccharide
22%
Body Mass Index
22%
Neopterin
22%
Protein Glutamine Gamma Glutamyltransferase
19%
Calgranulin
19%
Immunoglobulin A
19%
Esophagogastroduodenoscopy
11%
Anthropometry
11%
Enzyme Immunoassay
11%
Forced Expiratory Volume
11%
Enteritis
11%
Lung Function
11%
Lipopolysaccharide Binding Protein
11%
Biological Marker
11%
Longitudinal Study
11%
Rectal Bleeding
9%
Endoscopy
9%
Disease Activity
9%
Serositis
9%
Duodenum Biopsy
9%